Understanding the T cell immune response in SARS coronavirus infection
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
The severe acute respiratory syndrome (SARS) epidemic started in late 2002 and swiftly spread across 5 continents with a mortality rate of around 10%. Although the epidemic was eventually controlled through the implementation of strict quarantine measures, there continues a need to investigate the SARS coronavirus (SARS-CoV) and develop interventions should it re-emerge. Numerous studies have shown that neutralizing antibodies against the virus can be found in patients infected with SARS-CoV within days upon the onset of illness and lasting up to several months. In contrast, there is little data on the kinetics of T cell responses during SARS-CoV infection and little is known about their role in the recovery process. However, recent studies in mice suggest the importance of T cells in viral clearance during SARS-CoV infection. Moreover, a growing number of studies have investigated the memory T cell responses in recovered SARS patients. This review covers the available literature on the emerging importance of T cell responses in SARS-CoV infection, particularly on the mapping of cytotoxic T lymphocyte (CTL) epitopes, longevity, polyfunctionality and human leukocyte antigen (HLA) association as well as their potential implications on treatment and vaccine development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574
Coronavirus Pathogenesis and the Emerging Pathogen Severe Acute Respiratory Syndrome Coronavirus
Weiss, S. R., & Navas-Martin, S. (2005) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.69.4.635-664.2005 · Cited by 1,256 · cited 1×
“Nevertheless, human convalescent-phase plasma seemed to shorten hospitalization without adverse effects if it is administered as an immunotherapy to SARS patients early in the course of infection.”
Traggiai, E., Becker, S., Subbarao, K., Kolesnikova, L., Uematsu, Y., Gismondo, M. R., Murphy, B. R., Rappuoli, R., & Lanzavecchia, A. (2004) · Nature Medicine · doi:10.1038/nm1080 · Cited by 697 · cited 1×
“64, 65 Although it is still not known whether naturally acquired immune responses can confer protection from re-infection of SARS-CoV, vaccines are likely to be the most effective way to provide protection against a future re-emergence of SARS-CoV.”
Tang, F., Quan, Y., Xin, Z.-T., Wrammert, J., Ma, M.-J., Lv, H., Wang, T.-B., Yang, H., Richardus, J. H., Liu, W., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.0903490 · Cited by 496 · cited 1×
“75 This seems to suggest that SARS-CoV-specific T cell response could persist longer and thus indicating that cell-mediated immune response is important for protecting against re-infection.”
Zhao, J., Zhao, J., & Perlman, S. (2010) · Journal of Virology · doi:10.1128/jvi.01049-10 · Cited by 340 · cited 2×
“73 In addition, CD4 1 T cells in a senescent mouse model were found to play an important role in viral clearance in a primary infection with SARS-CoV. 72 In humans, SARS-CoV-specific memory T cells were found to persist in the peripheral blood of SARS patients up to 6 years Figure 1 Diagram showing the cytokine profil…”
Chen, H., Hou, J., Jiang, X., Ma, S., Meng, M., Wang, B., Zhang, M., Zhang, M., Tang, X., Zhang, F., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.591 · Cited by 75
Research works printed but not linked: 69
- 10.1016/S0140-6736(03)14630-2 · DOI · Paper page
- 10.1016/S0140-6736(03)13077-2 · DOI · Paper page
- 10.1056/NEJMoa030781 · DOI · Paper page
- 10.1016/S0140-6736(03)15259-2 · DOI · Paper page
- 10.1073/pnas.0506735102 · DOI · Paper page
- 10.1126/science.1118391 · DOI · Paper page
- 10.1016/S0022-2836(03)00865-9 · DOI · Paper page
- 10.1126/science.1085952 · DOI · Paper page
- 10.1126/science.1085953 · DOI · Paper page
- 10.1099/0022-1317-81-4-853 · DOI · Paper page
- 10.1128/CMR.00023-07 · DOI · Paper page
- 10.1016/j.antiviral.2006.05.010 · DOI
- 10.1016/j.virusres.2007.10.009 · DOI · Paper page
- 10.1111/j.1469-0691.2004.01009.x · DOI · Paper page
- 10.1073/pnas.0403492101 · DOI · Paper page
- 10.1128/JCM.42.4.1570-1576.2004 · DOI
- 10.1128/JVI.78.11.5612-5618.2004 · DOI · Paper page
- 10.1182/blood-2003-11-4072 · DOI
- 10.1016/j.bbrc.2006.03.152 · DOI
- 10.4049/jimmunol.177.4.2138 · DOI
- 10.1186/1471-2172-10-61 · DOI
- 10.1016/j.vaccine.2010.08.013 · doi:10.1016/j.vaccine.2010.08.013
- 10.1016/j.vaccine.2006.03.058 · DOI
- 10.1016/j.vaccine.2011.06.100 · DOI
- 10.1016/j.virol.2006.03.036 · DOI · Paper page
- 10.1086/422040 · DOI · Paper page
- 10.1016/S0145-305X(99)00072-5 · DOI · Paper page
- 10.1128/jvi.71.10.7889-7894.1997 · DOI
- 10.1371/journal.pone.0000024 · DOI · Paper page
- 10.1128/JVI.05039-11 · DOI · Paper page
- 10.4049/jimmunol.181.8.5490 · DOI · Paper page
- 10.1016/S0140-6736(03)14962-8 · DOI · Paper page
- 10.1016/j.imlet.2004.01.001 · DOI · Paper page
- 10.1016/j.virol.2004.10.016 · DOI · Paper page
- 10.1016/j.bbrc.2005.01.048 · DOI
- 10.1128/JVI.78.9.4638-4645.2004 · DOI · Paper page
- 10.1016/j.vaccine.2009.04.001 · DOI · Paper page
- 10.1099/vir.0.82839-0 · DOI · Paper page
- 10.1128/CVI.00261-08 · DOI
- 10.1007/s00705-009-0409-6 · DOI · Paper page
- 10.1182/blood-2005-12-4818 · DOI · Paper page
- 10.1084/jem.20062363 · DOI · Paper page
- Zhu M. SARS Immunity and Vaccination. Cell Mol Immunol2004; 1: 193–198.
- 10.1006/scbi.1996.0045 · DOI
- 10.1128/JVI.76.10.4792-4797.2002 · doi:10.1128/jvi.76.10.4792-4797.2002
- 10.1086/321005 · DOI · Paper page
- 10.1046/j.1365-2893.2001.00289.x · doi:10.1046/j.1365-2893.2001.00289.x
- 10.1186/1471-2350-4-9 · DOI · Paper page
- 10.1128/JCM.44.2.359-365.2006 · DOI
- 10.1086/421523 · DOI · Paper page
- 10.1089/vim.2011.0024 · DOI · Paper page
- 10.1034/j.1399-0039.2000.550314.x · DOI · Paper page
- 10.1146/annurev.med.54.101601.152346 · DOI · Paper page
- 10.1038/nature03113 · DOI · Paper page
- 10.4049/jimmunol.176.7.4094 · DOI · Paper page
- 10.1002/hep.21049 · DOI · Paper page
- 10.4049/jimmunol.172.7.4435 · DOI
- 10.1111/j.1469-0691.2004.00956.x · DOI · Paper page
- 10.1002/jmv.20499 · DOI · Paper page
- 10.1073/pnas.0307140101 · DOI · Paper page
- 10.1016/j.vaccine.2004.11.075 · DOI · Paper page
- 10.1016/j.vaccine.2005.08.055 · DOI · Paper page
- 10.1016/j.vaccine.2011.06.111 · DOI
- 10.1111/j.1365-2567.2010.03231.x · DOI
- 10.1099/vir.0.81579-0 · DOI · Paper page
- 10.1016/j.virol.2005.01.042 · DOI
- 10.1128/JVI.01281-09 · DOI · Paper page
- 10.1371/journal.ppat.1000636 · DOI · Paper page
- 10.1128/JVI.00355-09 · DOI · Paper page
Cited by
The trinity of COVID-19: immunity, inflammation and intervention
Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. P. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0311-8 · Cited by 4,360
Immunological considerations for COVID-19 vaccine strategies
Jeyanathan, M., Afkhami, S., Smaill, F., Miller, M. S., Lichty, B. D., & Xing, Z. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-00434-6 · Cited by 1,015
Considering how biological sex impacts immune responses and COVID-19 outcomes
Scully, E. P., Haverfield, J., Ursin, R. L., Tannenbaum, C., & Klein, S. L. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0348-8 · Cited by 932
Immune response, inflammation, and the clinical spectrum of COVID-19
García, L. F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01441 · Cited by 739
COVID-19: A promising cure for the global panic
Vellingiri, B., Jayaramayya, K., Iyer, M., Narayanasamy, A., Govindasamy, V., Giridharan, B., Ganesan, S., Venugopal, A., Venkatesan, D., Ganesan, H., et al. (2020) · Science of The Total Environment · doi:10.1016/j.scitotenv.2020.138277 · Cited by 636
Metadata
- Authors
- Janice Oh, H.-L., Ken-En Gan, S., Bertoletti, A., & Tan, Y.-J.
- Venue
- Emerging Microbes & Infections
- Publisher
- Informa UK Limited
- Published
- 2012-07
- Volume
- 1
- Issue
- 1
- Pages
- 1-6
- ISSN
- 2222-1751 (ISSN-L)
- OpenAlex
- W2044518292
- Cited by
- 152
- References
- 6
- FWCI
- 0.40
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Understanding the T cell immune response in SARS coronavirus infection. https://app.cochat.ai/papers/10.1038/emi.2012.26
- The paper
- Janice Oh, H.-L., Ken-En Gan, S., Bertoletti, A., & Tan, Y.-J. (2012). Understanding the T cell immune response in SARS coronavirus infection. Emerging Microbes & Infections. https://doi.org/10.1038/emi.2012.26
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.